Health ❯ Healthcare ❯ Medical Research

Oncology

Lung Cancer Breast Cancer Prostate Cancer Pancreatic Cancer Glioblastoma Acute Myeloid Leukemia Colorectal Cancer Multiple Myeloma Immunotherapy Clinical Trials

GLP-1 Drugs Linked to Better Breast Cancer Survival in Large EHR Study

The analysis of health records cannot show the drugs caused the gains.

NEJM Study and FDA Access Advance Daraxonrasib for Pancreatic Cancer

AI Blood Test Maps Tumor Neighborhoods and Predicts Immunotherapy Response

AI Pathomics Tool Beats PD-L1 at Predicting Lung Cancer Immunotherapy Benefit

Zoldonrasib Shows Promising Early Efficacy in KRAS G12D Lung Cancer

AI Trained on Swedish Health Registries Flags Small Groups at High Melanoma Risk

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Cadonilimab Plus Chemo Delivers Strong Phase 2 Signal in Frontline Endometrial Cancer

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

Study Links PSMA PET/CT to 5-Year Outcomes, Informing Salvage Treatment After Prostatectomy

CNIO’s Triple-Drug Mouse Breakthrough on Pancreatic Cancer Moves Into a Cautious Preclinical Phase

CRISPR Scan Maps the Strength of Cancer-Driving CTNNB1 Hotspot Mutations

Spanish Team Eradicates Pancreatic Tumors in Mice With Triple-Drug Regimen, PNAS Study Finds

Triple-Drug Strategy Wipes Out Pancreatic Tumors in Mice, Study Finds

Trials Show Fecal Transplants Enhance Cancer Immunotherapy, Including Longer PFS in Randomized Kidney Study

Abemaciclib Shows Early Benefit Signal in Genetically Selected High-Grade Meningioma Trial

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

Splice-Switching ASO Collapses Oncogenic Circuit in Pancreatic Cancer Models

AstraZeneca’s LATIFY Phase 3 Finds No Survival Benefit for Ceralasertib Plus Imfinzi in Pre-Treated NSCLC

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers